CELLULAR RESEARCH, INC.

Biotech · Acquired

High-sensitivity RNA sequencing kits with molecular barcoding for single-cell gene expression analysis

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Biotech
Total capital
$2.2M
Federal grants
$2.1M
2 awards · 2014–2015
Rank in peer group#42 of 42
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
$63K
7 awards · Health and Human S
Rank in Biotech#348 of 4373
Granted patents
34
6 pending · first 2019
Rank in peer group#1 of 42

Capital timeline

2014201520162017FEDERAL ↑EQUITY ↓Cumulative $2.2M$1.5M$10K$10K$627K$19K$10K
2014201520162017FEDERAL ↑EQUITY ↓Cumulative $2.2M$1.5M$627K$19K$10K

Latest events

  • Federal contractHealth and Human S · Quote #-Q-0001075PRODUCT #-634100-PRECISE Wta Single Cell Kit (96 Well) - 2 Pack$5K
  • Federal contractHealth and Human S · Drugs And Biologicals$10K
  • Federal contractHealth and Human S · Ambis #1779573 Precise Single Cell Wta Kit 192 PRC-WTA-SC192 (a Complete Single Cell Wta Kit Containing (2) 96-WELL Wta Precise Encoding Plates And Wta Reagent Kit), Cat# 1001112, Qty 4 @ $4,800.00/EACH$19K
  • Federal contractHealth and Human S · Drugs And Biologicals$5K
  • Federal contractHealth and Human S · Drugs And Biologicals$5K
  • Federal grantHealth and Human S · Phase II · A molecular barcoding sequencing kit for highly efficient and accurate single cel$627K
  • Federal contractHealth and Human S · Medical- Laboratory Testing$10K
Show 2 earlier federal awards
  • Federal contractHealth and Human S · Single Cell Reagent And Encoding Plate Kits And Assay Pools$10K
  • Federal grantHealth and Human S · Phase II · A kit for massively parallel single cell gene expression analysis$1.5M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 42 peers

Line = median

Biotech · Instrument

  • Federal grantsBelow median
  • Granted patents#1 · top 2%
  • Linked publications#9 · top 21%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 34 granted of 40
  • PendingHybrid Targeted And Whole Transcriptome AmplificationUSPTOApplication 18780091
  • GrantedHybrid Targeted And Whole Transcriptome AmplificationUSPTOUS 12,071,617
  • PendingPrecise Delivery of Components into FluidsUSPTOApplication 18627190
Show all 40 patent records

Recent research by its founders

  • Combinatorial labeling of single cells for gene expression cytometry2015476 cites
  • Molecular Indexing with Precise Assays20150 cites
  • Molecular indexing enables quantitative targeted RNA sequencing and reveals poor efficiencies in standard library preparations2014116 cites
  • ATELERIX LIFE SCIENCES INCSimilar federal contract value in Biotech · $68K in contracts
  • Abpro CorpSimilar federal contract value in Biotech · $66K in contracts
  • RETROTHERAPY, LLCSimilar federal contract value in Biotech · $65K in contracts
  • Radiant Genomics, Inc.Similar federal contract value in Biotech · $63K in contracts
  • LEADSCOPE, INC.Similar federal contract value in Biotech · $62K in contracts
  • Emmaus Life Sciences, Inc.Similar federal contract value in Biotech · $60K in contracts

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .